A growing number of studies is demonstrating that the cargo of tumor-derived exosomes is specifically enriched in signaling molecules able to promote cancer progression and remodeling of the tumor microenvironment (104), and different cancer types have been reported to release EGFR- or ErbB2-containing exosomes (13, 95). This evidence concerns the gene ERBB2 and neoplasm.